| Computershare Limited (CPU) ORDINARY FULLY PAID |
Industrials |
$16,039 |
Change in substantial holding
|
26 Feb 2026 8:15AM |
$30.380 |
$27.730 |
fallen by
8.72%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$31 |
Half Yearly Report and Accounts
|
26 Feb 2026 8:15AM |
$0.160 |
$0.110 |
fallen by
31.25%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Eye Medical Limited recorded a group loss after tax of $3,365,000 for the six months ended 31 December 2025.
- The EBITDA-level loss was $2,204,000, showing an improvement from the previous year's loss.
- Revenue grew by 29% to $16,712,000 compared to the previous period.
- Gross margin improved to 70%, driven by production efficiency and pricing discipline.
- Operating expenses increased due to higher variable sales commissions and investments in clinical data and regulatory activities.
- The company has considered various financial strategies to ensure its continuation as a going concern.
- Nova Eye Medical Limited operates in two business segments: AlphaRET and Glaucoma Surgical Devices.
- The report highlights no impairment losses for the Glaucoma Surgical Devices segment as of 31 December 2025.
- No significant events occurred after the interim period that would affect the company’s operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ballard Mining Limited (BM1) ORDINARY FULLY PAID |
Materials |
$183 |
Baldock Mineral Resource Exceeds 1 Moz
|
26 Feb 2026 8:14AM |
$0.825 |
$0.615 |
fallen by
25.45%
|
|
BM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Baldock Mineral Resource Estimate updated with over 86,000 meters of drilling.
- Ballard Mining aims for a Maiden Ore Reserve estimation by mid-2026.
- Baldock deposit contains over 669,000 ounces of Indicated material.
- Total Mineral Resource for Baldock exceeds 1 million ounces of gold.
- Company targets to de-risk initial years of mining with a minimum eight-year mine life.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Corporate Travel Management Limited (CTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,351 |
1HFY26 (Unaudited) Trading Update
|
26 Feb 2026 8:14AM |
$16.070 |
$16.070 |
fallen by
0%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,836 |
Appendix 4D and FY26 Interim Financial Report
|
26 Feb 2026 8:12AM |
$14.070 |
$12.560 |
fallen by
10.73%
|
|
SUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 4.2% to $2,194.7 million.
- Net profit after tax decreased by 19.8% to $104.1 million.
- Supercheap Auto's sales grew by 5.1% with strong online growth.
- rebel's sales increased by 4.8% despite a decline in gross margin.
- BCF and Macpac segments also contributed to revenue with varied results.
- Ongoing investments were made in store expansions and technology.
- An interim dividend of 32.0 cents per share was declared.
- Online sales growth was robust, particularly for Supercheap Auto and rebel.
- The company continues to manage costs amid elevated promotional activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$71 |
Appendix 4D and Half Yearly Report
|
26 Feb 2026 8:12AM |
$0.490 |
$0.390 |
fallen by
20.41%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma Limited reported a total comprehensive loss of AUD 5,787,938 for the half year ended 31 December 2025.
- The company did not declare or pay any dividends during the current or previous period.
- Revenue and other income for the period were AUD 587,060, with significant expenses in research and development.
- The company's cash position was strong with AUD 25,781,022 in cash and cash equivalents as of 31 December 2025.
- LTR Pharma's equity investments include a stake in LevOmega Pty Ltd, where it holds a 43% share.
- The share-based payments reserve increased to AUD 3,527,751 by the end of 2025.
- The financial report was reviewed by auditors with no contraventions noted under the Corporations Act 2001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$251 |
Fixed site enforcement contract expansion in WA
|
26 Feb 2026 8:12AM |
$1.705 |
$1.485 |
fallen by
12.90%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Expansion of fixed site enforcement agreement with WA Road Safety Commission.
- Additional fixed sites to be deployed from the second half of 2026 through 2027.
- Incremental contract value of approximately $11.2 million.
- Follows expansion of the trailer-based enforcement program.
- Focuses on detecting road traffic offenses using AI technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$251 |
Acusensus 1H FY26 Investor Presentation
|
26 Feb 2026 8:11AM |
$1.705 |
$1.485 |
fallen by
12.90%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 40% in 1H FY26.
- International operations account for 22% of total revenue.
- A $30 million equity raise was completed in December 2025.
- A litigation settlement impacted net profitability resulting in a $20.8 million loss in 1H FY26.
- New and expanded contracts significantly contributed to revenue growth.
- Significant investments in technology innovation and international expansion.
- A new Citibank facility was established to provide additional financial support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$251 |
Acusensus 1H FY26 Results Release
|
26 Feb 2026 8:11AM |
$1.705 |
$1.485 |
fallen by
12.90%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased 40% to $40.3 million in 1H FY26.
- Significant international revenue growth, contributing 22% to group revenue.
- Secured a major contract with Connecticut Department of Transportation.
- Expanded operations in Australia and New Zealand.
- Launched Forsite division for predictive road worker safety.
- Completed a $30 million capital raise and established a new debt facility.
- Net loss of $20.8 million mainly due to litigation settlement expenses.
- Strong cash balance of $41 million as of 31 December 2025.
- Projected FY26 revenue in the range of $83 to $87 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$251 |
Acusensus Appendix 4D and Half-Year Financial Report
|
26 Feb 2026 8:11AM |
$1.705 |
$1.485 |
fallen by
12.90%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 40% to $40.3 million, driven by new contracts and market expansion
- Reported a loss of $20.8 million due to increased costs and litigation expenses
- $16 million settlement reached with Redflex Traffic Systems Pty Ltd
- New and expanded contracts in Western Australia, Connecticut, and Queensland
- Completion of a $30 million capital raise to support growth
- Auditors reviewed the financial statements, finding them compliant with standards
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$68,343 |
Update - Notification of buy-back - CSL
|
26 Feb 2026 8:11AM |
$145.110 |
$140.820 |
fallen by
2.96%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$135 |
Update - Notification of buy-back - VLS
|
26 Feb 2026 8:10AM |
$2.485 |
$2.480 |
fallen by
0.20%
|
|
| United Overseas Australia Limited (UOS) ORDINARY FULLY PAID |
Real Estate |
$259 |
Preliminary Final Report
|
26 Feb 2026 8:10AM |
$0.700 |
$0.740 |
risen by
5.71%
|
|
UOS - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating profit for 2025 was $269.7 million, a 48.1% increase over 2024.
- Net profit attributable to company members was $148.1 million.
- A final dividend of 2.00 cents per share was declared.
- Net cash inflow from operating activities was $153.1 million.
- Net tangible asset backing per share was $1.24.
- Growth in property development operations, particularly in Vietnam and Malaysia.
- The company's net debt to equity ratio improved to 12.5%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Babylon Pump & Power Limited (BPP) ORDINARY FULLY PAID |
Industrials |
$12 |
FY26 Half Year Financial Report Announcement
|
26 Feb 2026 8:10AM |
$0.105 |
$0.094 |
fallen by
10.48%
|
|
| Babylon Pump & Power Limited (BPP) ORDINARY FULLY PAID |
Industrials |
$12 |
Half Yearly Report and Accounts
|
26 Feb 2026 8:10AM |
$0.105 |
$0.094 |
fallen by
10.48%
|
|
BPP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased slightly by 1.3% to $17.6 million.
- Reported EBITDA showed a significant decline, with a 211.7% change.
- Loss for the period was $7,158,662.
- No dividends were declared for the period.
- Successful integration of Matrix Hydro Services and Blue Hire.
- Rental segment revenue increased by 211.8%.
- Divestment of Pilbara Trucks Pty Ltd.
- Strategic share consolidation on a 30-1 basis.
- New contracts secured for future revenue visibility.
- Auditor's review concluded no significant issues affecting the financial report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$6,862 |
Update - Notification of buy-back - RMS
|
26 Feb 2026 8:10AM |
$4.760 |
$3.590 |
fallen by
24.58%
|
|
| Swift TV Limited (STV) ORDINARY FULLY PAID |
Communication Services |
$11 |
Notification of Investor Webinar
|
26 Feb 2026 8:09AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,301 |
Westgold Half Year Financial Report
|
26 Feb 2026 8:09AM |
$7.810 |
$5.610 |
fallen by
28.17%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $1,237.6 million for the half-year ended 31 December 2025.
- Profit before tax increased to $270.7 million from $4.6 million in the prior period.
- Profit after tax for members reached $190.7 million, up from a loss of $27.6 million in 2024.
- Cash flows from operating activities were $531.7 million.
- Investing activities resulted in a cash outflow of $135.7 million.
- Ore reserves and mineral resources saw significant growth, underscoring Westgold’s commitment to long-term expansion.
- Westgold's acquisition of the Bluebush Accommodation Village supports expanding operations in Southern Goldfields.
- The company issued and repurchased shares, impacting overall equity and share capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Everest Metals Corporation Ltd (EMC) ORDINARY FULLY PAID |
Materials |
$32 |
EMC Lodges Patent Application for Rubidium Extraction
|
26 Feb 2026 8:09AM |
$0.145 |
$0.120 |
fallen by
17.24%
|
|
| Black Cat Syndicate Limited (BC8) ORDINARY FULLY PAID |
Materials |
$688 |
Fingals & Majestic online, Lakewood expansion approved
|
26 Feb 2026 8:09AM |
$1.440 |
$0.945 |
fallen by
34.38%
|
|
BC8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Lakewood Mill expansion approved to 1.5Mtpa.
- Expansion capital cost is AUD 20 million.
- First processing of Fingals and Majestic ore through Lakewood Mill.
- Improved operating margin with transition to 100% owned ore.
- Regulatory approvals in place for expansion.
- Expansion to be completed in 12 months.
- Black Cat funded expansion from operating cashflow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Frontier Minerals Limited (NFM) ORDINARY FULLY PAID |
Materials |
$14 |
OTC Markets Presentation
|
26 Feb 2026 8:08AM |
$0.018 |
$0.008 |
fallen by
55.56%
|
|
| Black Pearl Group Limited (BPG) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$62 |
Capital Change Notice and Warrant Conversion Notice
|
26 Feb 2026 8:08AM |
$0.795 |
$0.640 |
fallen by
19.50%
|
|
| Bhagwan Marine Limited (BWN) ORDINARY FULLY PAID |
Industrials |
$123 |
Dividend/Distribution - BWN
|
26 Feb 2026 8:08AM |
$0.445 |
$0.390 |
fallen by
12.36%
|
|
| Iluka Resources Limited (ILU) ORDINARY FULLY PAID |
Materials |
$2,837 |
Application for quotation of securities - ILU
|
26 Feb 2026 8:08AM |
$6.160 |
$6.580 |
risen by
6.82%
|
|
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$28 |
Exclusive LMFP Licence Agreement Secured
|
26 Feb 2026 8:08AM |
$0.310 |
$0.155 |
fallen by
50%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebird Metals secured exclusive LMFP licence agreement.
- The agreement covers five LMFP patents until 2045, excluding China.
- Licensing registered with Chinese authorities.
- Enhances Firebird's intellectual property portfolio.
- Supports Australian Demonstration Plant and battery supply chain opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
